Background-Fragmented QRS (fQRS) has been shown to predict cardiac events in select patient populations. Whether fQRS improves patient selection for primary prevention patients eligible for implantable cardioverter-defibrillator (ICD) therapy remains unknown. Methods and Results-In a prospective, multisite cohort of 842 patients with left ventricular dysfunction (ejection fraction Յ35%) representing both ischemic and nonischemic etiology, the presence of fQRS on ECG was assessed using standardized criteria. The association between fQRS and all-cause and arrhythmic mortality was evaluated overall and stratified by ICD status using 
A lthough prophylactic placement of implantable cardioverter-defibrillators (ICDs) reduces mortality rates among patients with left ventricular dysfunction, 1,2 ICD therapy is associated with significant upfront costs and many patients do not benefit directly from its use. In the Sudden Cardiac Death in Heart Failure Trial, only 1 in 5 patients randomly assigned to ICD treatment received appropriate therapy at 5 years. 3 Although a number of noninvasive risk stratification measures have been proposed to better identify individuals who may benefit from ICD placement, most require testing with additional costs, and no measure to date has consistently identified a low-risk group with sufficiently high negative predictive value to justify its routine use in clinical practice. 4 -5 
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Recently, fragmented QRS (fQRS), defined by unexpected deviations in the QRS morphology on a 12-lead ECG, has been shown to predict cardiac events in several populations. Pathophysiologically, fragmented QRS has been associated with regional myocardial scar, 6 -8 which is believed to be a substrate for ventricular arrhythmia. Clinically, fQRS has been associated with an increased mortality risk in patients with acute myocardial infarction, 9 higher rates of spontaneous ventricular fibrillation among patients with Brugada syndrome, 10 and to be of comparable prognostic value as potentials among patients with arrhythmogenic right ventricular dysplasia. 11 In a population referred for stress testing, fQRS was associated with higher rates of cardiac events 12 and, more recently, in patients with a wide QRS (Ն120 ms), fQRS was found to be an independent predictor of all-cause mortality. 13 In patients with left ventricular systolic dysfunction, fQRS has been shown to be a predictor of arrhythmic events but not of mortality, but this study evaluated only patients already with an ICD and included a heterogeneous sample of primary and secondary prevention patients. 14 Whether fQRS has prognostic utility in patients with left ventricular dysfunction eligible for primary prevention treatment with ICD therapy-the most common indication for ICD therapy-remains unknown. 15 To address this gap in knowledge, we studied fQRS in patients with left ventricular dysfunction in a prospective, multisite, community-based cohort. If fQRS is associated with a higher risk of all-cause and arrhythmic mortality, its use may improve selection for primary prevention patients eligible for ICD therapy.
Methods

Study Population
Between March 2001 and June 2004, a multicenter, prospective cohort of primary prevention patients from 7 large outpatient cardiology clinics was developed and coordinated by the Ohio Heart and Vascular Center and the Lindner Clinical Trials Center to evaluate the prognostic role of microvolt T-wave alternans. 16 Consecutive patients with left ventricular dysfunction (left ventricular ejection fraction [LVEF] Յ35%) of both ischemic and nonischemic etiologies were enrolled. Patients had to be 21 years or older, be in sinus rhythm for microvolt T-wave alternans assessment, and have no history of a ventricular arrhythmic event. All patients gave informed consent to registry enrollment and follow-up. The initial study design was approved by the Institutional Review Board at The Christ Hospital (Cincinnati, Ohio), and consent for this study was waived at Saint Luke's Mid America Heart Institute (Kansas City, Mo) as all study data were deidentified.
For this study, we were interested in evaluating the prognostic role of fQRS within this primary prevention population of patients with left ventricular dysfunction. Of the 968 original cohort patients, baseline ECGs in paper form were not available from 126 (13.0%). The final study cohort therefore included 842 patients. Importantly, there were no significant differences in demographic and clinical characteristics between those included and excluded from this cohort.
Study Variables
Independent Variables
The definition of fQRS has been previously described. 12 Briefly, among patients with a narrow QRS Ͻ120ms, fQRS was defined by various RSRЈ patterns, including the presence of an additional R wave (RЈ), notching in the nadir of the S wave, notching in the R wave, or Ͼ1 RЈ in at least 2 contiguous leads corresponding to a myocardial territory. 12 Myocardial territories were defined as follows: (1) anterior distribution: ECG leads V 1 -V 5 ; (2) lateral distribution: ECG leads I, AVL, and V 6 ; and (3) inferior distribution: ECG leads II, III, and AVF. Among patients with a QRS Ն120 ms, fQRS was assessed in patients with right or left bundle-branch block, paced rhythms, and premature ventricular contractions using additional criteria described in a recent study. 13 Finally, the presence or absence of pathological Q waves, suggesting prior myocardial infarction, was also determined. Pathological Q waves were defined as those Ն0.04 seconds in duration and exceeding one fourth of the following R-wave voltage in at least 2 contiguous ECG leads corresponding to a myocardial territory as defined above. 6 Before coding ECGs for fQRS, we requested 20 ECGs from Dr Mithilesh Das, who helped develop the fQRS criteria to verify our accuracy in fQRS interpretation. 12 These ECGs were reviewed by 2 independent reviewers (A.C. and A.K.) from this study who were blinded to the "official" fQRS results. These interpretations were then matched with those coded by Dr Das's group and were found to be 100% concordant with their interpretations. After verifying accuracy in fQRS interpretation, our study reviewers then independently assessed the presence of fQRS and Q waves in ECGs from patients in this study cohort, and a third expert reader (A.W.) adjudicated cases of discordant readings. All ECGs were standard 12-lead ECGs (filter range of 0.15 to 150 Hz; 25 mm/s; 10 mm/mV). Importantly, all 3 readers were blinded to study outcomes, and the concordance rate between the 2 readers for assessing fQRS in this study was excellent, at 97%.
Study Outcomes
The primary end point for the study was all-cause mortality. Secondary end points included cause-specific mortality and the delivery of appropriate shocks in patients with ICDs. The decision for ICD placement was at the discretion of the patient's physician, and device programming was not protocol-specified. Cause-specific mortality was determined by 2 study team members blinded to the decedent's fQRS status and was classified as arrhythmic or nonarrhythmic in etiology using a modified Hinkle-Thaler system. 17 Arrhythmic deaths included unwitnessed deaths (if stable when last observed before death), witnessed sudden deaths, and deaths as a sequelae of cardiac arrest. 17 In patients with ICDs, shocks were reviewed by a physician blinded to fQRS status to determine their appropriateness. Follow-up for clinical end points was obtained through September 2007 and was achieved by quarterly office visits, telephone follow-up, review of office charts, and an annual query of the National Death Index.
Other Study Variables
Other data collected at study enrollment included patient demographics (age and sex), clinical characteristics (LVEF, presence or absence of ICD, diabetes mellitus, hypertension, symptomatic heart failure, chronic obstructive pulmonary disease, chronic renal insufficiency, peripheral vascular disease, and history of myocardial infarction, stroke, transient ischemic attack, atrial fibrillation, unexplained syncope, and revascularization therapy), and medication treatment at the time of enrollment (aspirin, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, ␤-blocker, digoxin, diuretic, class I or III antiarrhythmic agents, statin, and spironolactone). In addition, Holter testing was performed on all patients and was reported as abnormal if nonsustained ventricular tachycardia (defined as Ͼ100 beats per minute for Ն3 consecutive beats and Ͻ30 seconds) was detected.
Statistical Analyses
Because ICD use would significantly affect mortality outcomes in a study population with left ventricular dysfunction, we determined a priori to stratify analyses by ICD status. The rationale for stratified analyses was to ensure appropriate comparisons of fQRSϩ and fQRSϪ patients with the same ICD status. Baseline characteristics between those patients identified with and without fQRS were compared using Student t tests for continuous variables and 2 tests for categorical variables. Survival curves between the fQRSϩ and fQRSϪ patient groups were constructed using Kaplan-Meier estimates, and the unadjusted relationship of fQRS with mortality was assessed with the stratified log-rank test.
Stratified multivariable Cox proportional hazards models were then constructed to assess the independent relationship of fQRS with all-cause mortality, adjusting for the previously described demographic, clinical, and medication treatment variables. Covariates associated with survival in univariate analyses (PՅ0.20) were included in the final model. Because of their known association with survival, age and LVEF were also included in the final model regardless of the level of significance. Potential 2-way interactions between covariates were also examined.
Additionally, we conducted secondary analyses to examine whether the association of fQRS with mortality differed within the following patient subgroups: presence or absence of ICD, etiology (ischemic versus nonischemic) of left ventricular dysfunction, wide (Ն120 ms) versus normal (Ͻ120 ms) QRS duration, and the presence of fQRS in individual anatomic territories (anterior, inferior, lateral). Finally, in patients with ICDs, we assessed whether fQRS was an independent predictor of arrhythmic mortality and appropriate ICD shock therapy. In all Cox proportional hazards models, the assumption of proportionality was not violated based on the statistical test using Schoenfeld residuals.
For our power calculations, we estimated that fQRS would need to be associated with at least a 1.5-to 2-fold increased risk for all-cause mortality for it to have sufficient negative predictive value for use in patient selection for ICD therapy. Assuming that 33% of patients in the cohort will have fQRS on ECG and an overall mortality rate of 20%, our study would need to have 472 patients to have 95% statistical power to detect a minimum detectable hazard ratio of 2.0 at a 2-sided significance level of 0.05. Similarly, our study would need to have 787 patients to have 80% statistical power to detect a minimum detectable hazard ratio of 1.5 at a 2-sided significance level of 0.05. All statistical analyses were performed with SAS version 9.2 (Cary, NC) and R version 2.10.0. Dr Chan had full access to all of the data and takes full responsibility for the integrity of the data and the accuracy of the data analysis.
Results
Baseline Characteristics
Of 842 patients in the study cohort, fQRS was present in 274 (32.5%) patients. Mean follow-up for the entire cohort was 40Ϯ17 months and was similar between the fQRS groups. Mean age was 66Ϯ12 years, 31% of patients had a QRS Ն120 ms on baseline ECG, and 77% had an ischemic etiology to their left ventricular dysfunction. Table 1 compares the baseline characteristics of the study cohort by fQRS group. In general, most clinical characteristics were similar between those with and without fQRS, including age, LVEF, and the majority of clinical and medication treatment variables. However, patients with fQRS were more likely to be male, have an ischemic etiology for their left ventricular dysfunction, and higher rates of prior myocardial infarction, Q waves on ECG, and coronary revascularization.
Unadjusted Analyses
A total of 191 (22.7%) patients died during study follow-up, of which 54 (19.7%) were in the fQRSϩ group and 137 (24.1%) were in the fQRSϪ group (Table 2) . Unadjusted rates of event-free survival on Kaplan-Meier plots were similar between the fQRS groups (stratified log-rank statistic probability value of 0.15) (Figure) . Arrhythmic deaths were seen in 99 (11.8%) patients and were similar between those in whom fQRS was present (27 deaths [9 When considering only patients with a prior ICD implant, rates of death from all causes were similar between patients in whom fQRS was present (20.9%) and absent (22.7%); Pϭ0.67) ( Table 3) . Similarly, among patients without a prior ICD implant, rates of death from all causes were similar between patients in whom fQRS was present (18.2%) and absent (25.5%; Pϭ0.11). Finally, within each ICD group, rates of arrhythmic and nonarrhythmic mortality were similar between fQRS groups (see Table 3 ).
Adjusted Analyses
Independent predictors of all-cause mortality are depicted in Table 4 . In stratified multivariable Cox regression models, the presence of fQRS was not associated with a higher risk of all-cause mortality (hazard ratio [HR], 0.88; 95% confidence interval [CI], 0.63-1.22; Pϭ0.43). Other clinical variables, including older age, lower LVEF, diabetes mellitus, peripheral vascular disease, and unexplained syncope, were associated with higher all-cause mortality.
Similarly, fQRS was not independently associated with a higher risk of arrhythmic mortality (HR, 0.77; 95% CI, 0.49 -1.31; Pϭ0.38) or nonarrhythmic mortality (HR, 1.10; 95% CI, 0.69 -1.74; Pϭ0.70) ( Table 5 ). Additionally, there was no evidence that fQRS had prognostic utility when patients were stratified by ICD status, the etiology of left ventricular dysfunction, QRS duration, or when examined by individual myocardial territories (ie, presence of fQRS in anterior, posterior/inferior, or lateral distributions) (see Table 5 ). Finally, the presence of fQRS was not associated with a higher risk of arrhythmic death and appropriate ICD shock among ICD recipients.
Discussion
In this multicenter, prospective cohort of primary prevention patients with left ventricular dysfunction, we found that fQRS was not associated with a higher risk of either all-cause or arrhythmic mortality. Additional secondary analyses did not demonstrate that fQRS was associated with a higher mortality risk by ICD status, myocardial territory for fQRS, etiology of left ventricular dysfunction, or QRS duration on ECG. Collectively, these findings suggest that fQRS is unlikely to be of benefit in patient selection for primary prevention ICD therapy among patients with left ventricular systolic dysfunction.
Although limited studies have shown that fQRS is associated with regional myocardial scar and cardiac events, they have not consistently evaluated mortality outcomes. Initial studies found that fQRS was a more sensitive marker with a higher negative predictive value for myocardial scar than Q waves on ECG. 6 Subsequent studies found that fQRS in patients referred for stress testing was associated with a higher risk for cardiovascular events (hospitalization, revascularization, and cardiac death) but was not associated with higher adjusted rates of mortality (HR, 1.07; 95% CI, 0.82-1.34). 12 More recently, fQRS has been identified as a predictor of all-cause mortality in patients with a wide QRS on ECG, but this population was not restricted to patients with left ventricular dysfunction, and the mean LVEF in this study was 44%. 13 Finally, in patients with an acute myocardial infarction, fQRS was found to be an independent predictor of mortality. 9 Although fQRS has been studied in these patient populations, these groups are not routinely eligible for primary prevention ICD treatment. To our knowledge, this is the first study to restrict the evaluation of fQRS to patients with left ventricular dysfunction who would be potentially eligible for ICD therapy for primary prevention. The key role of a noninvasive risk stratification tool (such as fQRS) in patients with left ventricular dysfunction would be its ability to identify patients at high and low risk for mortality to enhance patient selection. In this study, we did not find that fQRS predicted higher mortality in patients with left ventricular dysfunction despite more than 3 years of follow-up. Importantly, our study had Ͼ95% power to detect a minimum Figure. Kaplan-Meier survival curves based on fQRS status. Unadjusted event-free survival plots for the fQRS groups revealed no differences in overall survival during follow-up (stratified log-rank statistic probability value of 0.15). hazard ratio of 2.0 and Ͼ80% power to detect a minimum hazard ratio of 1.5. Based on the 95% CIs of our findings and these power calculations, it is therefore unlikely that fQRS will be useful for decisions about patient selection for ICD therapy in primary prevention patients with left ventricular dysfunction-the most common indication for ICD treatment.
In patients with left ventricular dysfunction, an important mechanism for the occurrence of ventricular arrhythmias is the presence of myocardial fibrosis. Cardiac MRI studies have shown that myocardial fibrosis represents an arrhythmogenic substrate in patients with ischemic (caused by prior infarct) 18 as well as nonischemic cardiomyopathy (caused by midwall fibrosis). 19 Although fQRS has been shown to correlate with regional scar on myocardial perfusion imaging, 6 it may be a relatively insensitive marker of the more diffuse myocardial fibrosis process seen in patients with cardiomyopathies. 18 -19 Alternatively, not all myocardial scar may result in ventricular arrhythmia, 18 and there may be heterogeneity in myocardial scar formation in patients with left ventricular dysfunction.
Our study should be interpreted in the context of the following limitations. First, as in all cohort studies, there exists the potential for residual confounding despite our efforts to adjust for differences. However, as we did not find an association between the fQRS groups even on unadjusted analyses, it is unlikely that the lack of an association between fQRS and mortality in this study is attributable to residual confounding. Second, there may be variations across centers in the accuracy of fQRS interpretation. However, we took special precautions to ensure that the ECG interpretations by our reviewers were consistent with those who developed the fQRS criteria. 6 Our reviewers' interpretation of fQRS was 100% concordant with their readings, and our intrastudy concordance rate of 97% suggests that such variation was unlikely to be the reason for the negative study findings. Third, we did not collect data on rates of antitachycardia pacing in patients with ICDs. Nonetheless, we found that rates of arrhythmic deaths were similar between the fQRS groups in patients without ICDs; moreover, the clinical significance of antitachycardia pacing in a composite end point with arrhythmic deaths is unclear. 20 Fourth, although there is the potential for misclassification of arrhythmic deaths, such misclassification is unlikely to have meaningfully affected our results for this secondary end point, as any misclassification would have been "nondifferential," that is, to have affected fQRSϩ and fQRS-patients equally. Finally, since all patients had to be in sinus rhythm at enrollment for this cohort, our findings may not apply to patients in atrial fibrillation or atrial flutter. However, these patients comprised only a minority (8% to 15%) of clinical trial patients with left ventricular dysfunction, 1,2 and their inclusion is unlikely to have changed the study findings.
Conclusion
In patients with moderate to severe left ventricular dysfunction, the presence of fragmented QRS on ECG was not associated with a higher risk for either all-cause or arrhythmic mortality. Our findings do not provide evidence that fragmented QRS would be effective in risk stratifying primary prevention patients eligible for ICD therapy. Secondary analyses, which evaluated the association between fQRS and cause-specific mortality and appropriate ICD shocks in ICD recipients, are depicted. Additionally, subgroup analyses evaluating the relationship between fQRS and all-cause mortality by ICD status, etiology of left ventricular dysfunction, QRS duration, and myocardial territory of fQRS are shown.
*Assessed only in patients with ICDs.
